arrow attorney-female attorney-male btn-close btn-menu checkmark document facebook ArtboardCreated with Sketch. instagram linkedin play twitter youtube
Attorney Referrals
Free Case Review - 24/7 - Nationwide
(888) 485-8844

Quick Search

Search results will appear here
Ferrer Poirot Wansbrogh Feller Daniel Logo
  • About Us
    • Meet Our Attorneys
    • FAQ
  • Cases We Handle
  • Contact Us
  • Attorney Referrals
Ferrer Poirot Wansbrogh Feller Daniel Logo
  • About Us
    • Meet Our Attorneys
    • FAQ
  • Cases We Handle
  • Contact Us
  • Attorney Referrals
Free Case Review - 24/7 - Nationwide

Search Results

Search Results: Arterial Dissection Lawsuits

Lemtrada
In 2001, the U.S. Food and Drug Administration (FDA) approved a medication called alemtuzumab to help treat B-cell chronic lymphocytic leukemia, a type of cancer. In 2014, the same drug was approved by the FDA for the treatment of multiple sclerosis (MS). Sanofi Genzyme soon released a version of the drug for MS patients under the brand name Lemtrada. Since (more...)
Ferrer Poirot Wansbrogh Feller Daniel Logo
  • Blog
  • Disclaimer
  • Privacy Policy
  • Sitemap
Principal Office: 2603 Oak Lawn, Suite 300, Dallas, Texas 75219

Tel: (800) 210-8503

No fee if no recovery. You will never pay court costs and expenses we incur unless we settle your claim. Client is obligated for payment of court costs and expenses, such as medical expenses. Cases may be referred for the purpose of advancing your claim with your best interests as our primary concern. Attorneys Jesse Ferrer and Matt Daniel are responsible for the content of this website.

2023 © All rights reserved Ferrer, Poirot & Wansbrough | Law Firm Marketing by cj Advertising